K
Koichi Furukawa
Researcher at Kobe University
Publications - 11
Citations - 204
Koichi Furukawa is an academic researcher from Kobe University. The author has contributed to research in topics: Medicine & Antibody. The author has an hindex of 4, co-authored 11 publications receiving 67 citations.
Papers
More filters
Journal ArticleDOI
Early Differences in Cytokine Production by Severity of Coronavirus Disease 2019.
Lidya Handayani Tjan,Koichi Furukawa,Tatsuya Nagano,Tatsunori Kiriu,Mitsuhiro Nishimura,Jun Arii,Yasuhisa Hino,Sachiyo Iwata,Yoshihiro Nishimura,Yasuko Mori +9 more
TL;DR: In this paper, the authors measured serum cytokine levels in 95 patients with COVID-19 during the infection's acute phase and reported that significantly higher interleukin 12 and 2 levels were induced in patients with asymptomatic or mild disease than in those with moderate or severe disease.
Journal ArticleDOI
Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer.
Masahiro Katsurada,Tatsuya Nagano,Motoko Tachihara,Tatsunori Kiriu,Koichi Furukawa,Kiyoko Koyama,Takehiro Otoshi,Reina Sekiya,Daisuke Hazama,Daisuke Tamura,Kyosuke Nakata,Naoko Katsurada,Masatsugu Yamamoto,Kazuyuki Kobayashi,Yoshihiro Nishimura +14 more
TL;DR: BTS is a predictive and prognostic negative factor of ICI therapy for NSCLC that is significantly shorter than that of those with a small BTS.
Journal ArticleDOI
Interaction between Immunotherapy and Antiangiogenic Therapy for Cancer.
TL;DR: A synergistic mechanism of immunotherapy and antiangiogenic therapy is described and current clinical trials of these combinations are summarized.
Posted ContentDOI
Cross-Neutralizing Activity Against SARS-CoV-2 Variants in COVID-19 Patients: Comparison of 4 Waves of the Pandemic in Japan.
Koichi Furukawa,Lidya Handayani Tjan,Silvia Sutandhio,Yukiya Kurahashi,Sachiyo Iwata,Yoshiki Tohma,Shigeru Sano,Sachiko Nakamura,Mitsuhiro Nishimura,Jun Arii,Tatsunori Kiriu,Masatsugu Yamamoto,Tatsuya Nagano,Yoshihiro Nishimura,Yasuko Mori +14 more
TL;DR: In this paper, the authors investigated the neutralizing potency of 81 coronavirus disease 2019 (COVID-19) patients' sera from the first to fourth waves of the pandemic against SARS-CoV-2 D614G, B.1.7, P.1, and B.351.